Receptor proteins are a class of important transmembrane biomacromolecules that control a diverse range of physiological processes. While a number of selective receptor-ligand interactions are key to the initiation of downstream cellular pathways, many other types of receptors are responsible for the endocytosis, and thus clearance, of harmful molecules from the circulation in blood. Some receptor proteins located on the surface of cells can facilitate the invasion of pathogens, however. 1 Recent studies have revealed an upregulation of carbohydrate receptors during inflammation and cancer metastasis. 2 As a result, receptor proteins are promising biomarkers for targeted disease diagnosis and therapy. [3] [4] [5] [6] [7] Since the discovery of graphene which has demonstrated exceptional mechanical, optical and electrical properties, increasing efforts have been directed to the development of two-dimensional (2D) graphene analogues for application in a variety of research areas. [8] [9] [10] [11] [12] In particular, recent literature has seen an extensive interest in the construction of diagnostic and therapeutic materials based on 2D transition metal dichalcogenides (TMDs). [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Compared to GO, the 2D TMDs are structurally more diverse, and some materials have proven to have a better biocompatibility for biological applications. [11] [12] [13] The 2D TMDs can be easily functionalized with a diverse range of biomolecules and drugs by supramolecular assembly for biosensing and cancer therapy. [14] [15] [16] Owing to their intrinsic photothermal and photoacoustic properties, these TMDs have also been used for in vivo cancer theranostics. [17] [18] [19] While these pioneering investigations have highlighted the promise of TMDs as a new generation of biomedical tools, evidence for the applicability of TMDs to targeted bio imaging has been elusive. ligand. The 2D MoS2 shows a much better working concentration range than GO, improving the imaging for both cellular and tissue samples. As shown in Fig. 1a , we used the glycoligand (galactose) for, the asialoglycoprotein carbohydrate receptor (ASGPr). 20 The glycoligand was coupled to a redemitting dicyanomethylene-4H-pyran (DCM) fluorescent dye by an efficient click reaction, producing glycoprobe (DK1) capable of cellular imaging (Fig. 1a) . 21, 22 Then, the receptor-targeting imaging ability of DK1 was investigated using both 2D MoS2 and GO (Fig. 1a) . GO was produced using the modified Hummer's method, 5 and 2D MoS2 was prepared using the recently established, simple liquid exfoliation method from commercial MoS2 powder. 23 The resulting 2D materials were characterized by a series of microscopic and spectroscopic techniques (Fig. 1). Fig  1b, Fig. 1c and Fig. 1d show the high-resolution transmission electron microscope (HRTEM) image of GO, scanning electron microscope (SEM) image of 2D MoS2 and TEM image of 2D MoS2, respectively. The objects observed in these images appear to be thin flakes. Dynamic light scattering (DLS) suggested a similar size distribution for the 2D MoS2 (Fig. 1e) and GO (Fig. 1f) sheets. Moreover, typical UV-vis and Raman peaks were observed for both materials. While a characteristic broad UV absorbance band for GO was observed, 24, 25 and typical absorbance peaks at 623 and 684 nm, assigned to the A1 and B1 direct exciton transitions of 2D MoS2, respectively, were observed. [26] [27] [28] The typical D band (1350 cm -1 ) and G band (1595 cm -1 ) indicated the presence of GO sheets, 5 whereas peaks centered at 404 and 378 cm -1 , which are the A1g (out-of-plane vibration of S) and E 1 2g (inplane relative motion between S and Mo) modes of hexagonal MoS2, respectively, suggest the formation of 2D MoS2. 29 In addition, the materials were also characterized using Zeta potential analysis (Fig. S1 ) and fluorescence spectroscopy (Fig.  S2) . The results indicate a negatively charged nature 30, 31 and weak intrinsic fluorescence emission of the 2D materials. With the fluorophore-labelled ligand and the 2D materials in hand, we performed cellular imaging assays. DK1 (at two different concentrations) with or without increasing amounts of 2D MoS2 or GO were incubated with Hep-G2 (human liver cancer) cells that significantly express ASGPr 20 for 15 min. Subsequently fluorescence images were recorded and the fluorescence intensities quantified (Fig. 2) . As shown in Fig. 2a , while the fluorescence imaging effect of the DK1 alone was weak for Hep-G2, the presence of increasing 2D MoS2 drastically increased the fluorescence. We also observed that the presence of increasing GO did not enhance the fluorescence under similar imaging conditions. To quantify these results, the fluorescence intensities of the cell lines were measured (Fig. 2b and Fig. 2c) . Similarly, the result indicate that the presence of increasing 2D MoS2 enhances the fluorescence of the cell lines (except for 40 μM DK1 with 500 μg mL -1 2D MoS2, Fig. 2c ). In contrast, the presence of increasing GO did not enhance the fluorescence. The only exception is the mixture of 40 μM DK1 with a small amount of GO (25 μg mL -1 and 50 μg mL -1 ). 32 However, further increase of the GO concentration led to sharp fluorescence quenching. This result suggests a better working concentration range for 2D MoS2 than GO. To test whether the fluorescence imaging is predominantly based on ASGPr-glycoligand interactions, we used a cervical cancer cell line (HeLa) and a lung cancer cell line (A549) without ASGPr expression as control. [33] [34] [35] From both fluorescence imaging (Fig. 3a) and quantification (Fig. 3b) we determined that the fluorescence for both cells quickly reached equilibrium.
Interestingly, over the whole time period, the material produced a stronger fluorescence with Hep-G2 than with HeLa and A549, suggesting that the enhancement was caused by ligand-ASGPr recognition events. Notably, the fluorescence imaging results were in good agreement with the ASGPr expression level of the cells, as determined by real-time quantitative polymerase chain reaction (RT-qPCR) (Fig. 3c) . Subsequently, we used tissue samples to investigate the imaging properties of the 2D materials. A female athymic BALB/c nu/nu mouse with a Hep-G2-bearing xenograft was used. 32 The collected tissue sections were the xenograft and two healthy organs, the spleen and the lung. We determined that with an increasing concentration of 2D materials, the fluorescence of DK1 gradually increased with xenograft section in the presence of 2D MoS2 (Fig. 4a and Fig. 4e ), but not for GO (Fig. 4b and Fig. 4f ). In addition, a fluorescence increase was not observed for the spleen (Fig. 4c and Fig. 4g ) or lung sections (Fig.  4d and Fig. 4g ), which were shown to hardly express ASGPr by RT-qPCR (Fig. 4h) .
In summary, we have demonstrated that 2D MoS2 can significantly enhance the fluorescence imaging ability of fluorophore-labelled ligand molecules for transmembrane receptors in a concentration dependent manner. Compared to GO, a 2D carbon material widely used for biosensing and bioimaging, the working concentration range for the 2D MoS2 was significantly improved. This research suggests that 2D materials with similar morphology but different chemical components might function differently at certain cellular interfaces. This study may also provide insight into the development of other effective low-dimensional materials for targeted theranostics. [36] [37] [38] [39] This research is supported by the 973 project (2013CB733700), the National Natural Science Foundation of China (21572058 and 21576088), the Shanghai Health and Family Planning Commission Research Fund (201540158), the Science and Technology 
